Cart
sales@molnova.com
Neoisoastilbin
CAS No. 54141-72-9
Neoisoastilbin( —— )
Catalog No. M21692 CAS No. 54141-72-9
Neoisoastilbin may have antioxidant and anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 275 | In Stock |
|
| 25MG | 465 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeoisoastilbin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeoisoastilbin may have antioxidant and anti-inflammatory activities.
-
DescriptionNeoisoastilbin may have antioxidant and anti-inflammatory activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorNO Synthase|TNF-α|IL Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54141-72-9
-
Formula Weight450.4
-
Molecular FormulaC21H22O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (222.03 mM)
-
SMILESC[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1O[C@H]([C@H](c(cc1)cc(O)c1O)Oc1c2c(O)cc(O)c1)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antioxidant and Anti-Inflammatory Activities of Phenolic-Enriched Extracts of Smilax glabra.Evid Based Complement Alternat Med. 2014;2014:910438.
molnova catalog
related products
-
Rutaevin
Rutaevin shows the inhibitory activity on nitric oxide (NO) production in lipopolysaccharide-activated RAW264.7 macrophages, it may be as a valuable anti-inflammatory agent.
-
Secologanic acid
Secologanic acid is a plant growth inhibitor, it shows inhibition of nitric oxide production in lipopolysaccharide-activated macrophages.
-
Epimagnolin B
Epimagnolin B has anti-inflammatory activity, it can inhibit the production of NO and PGE(2) and the expression of respective enzyme iNOS and COX-2 through the suppression of I-kappaB-alpha degradation and nuclear translocation of p65 subunit of NF-kappaB.
